RetinAI Medical AG develops healthcare solutions to protect patients from vision loss using artificial intelligence (AI). To achieve this goal, we build tools to collect, analyze and to organize health data, empowering healthcare professionals and patients. Our vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma and other Neurodegenerative disorders.